Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasodip-Combo 20 in Essential Hypertension
NCT01211314Phase 4Terminated
- Sponsor
- Meir Medical Center
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of enalapril, lercanidipine in essential hypertension, sponsored by Meir Medical Center. Started Jan 2011; status: terminated.
02
Drugs
enalaprillercanidipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01211314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211314.